Migraine Prevention Using ActiPatch

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

April 1, 2018

Study Completion Date

April 30, 2018

Conditions
Migraine
Interventions
DEVICE

Pulsed Shortwave Therapy

Stimulation of the supratrochlear and supraorbital branches of the ophthalmic nerve.

DEVICE

Placebo Pulsed Shortwave therapy

Placebo Stimulation of the supratrochlear and supraorbital branches of the ophthalmic nerve.

Trial Locations (1)

46032

Eppley Group, Indianapolis

Sponsors
All Listed Sponsors
lead

BioElectronics Corporation

INDUSTRY

NCT03166046 - Migraine Prevention Using ActiPatch | Biotech Hunter | Biotech Hunter